Who
Deborah Turner Kochevar
Director
Company insider
Files Form 4 as: Director, Elanco Animal Health; Director, Charles River Laboratories International.
In numbers
- Trades disclosed
- 258
- Buys
- 1
- Sells
- 14
- Bought
- $28K
- Sold
- $6.7M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 3 Nov 2008
- Last trade
- 21 May 2026
- Last filed
- 26 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 26 May 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —4,678 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —4,678 at $0.00 | filing |
| 28 Nov 2025filed 2 Dec 2025 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —10,314 at $0.00 | filing |
| 29 Nov 2024filed 3 Dec 2024 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —18,169 at $0.00 | filing |
| 13 May 2024filed 15 May 2024 | CRL Charles River Laboratories Internationaloption or derivative · Life-science tools | SEC FORM 4 Code A | $299K1,311 at $228.41 | filing |
| 13 May 2024filed 15 May 2024 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Code A | $128K559 at $228.41 | filing |
| 30 Nov 2023filed 4 Dec 2023 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —20,374 at $0.00 | filing |
| 15 May 2023filed 17 May 2023 | CRL Charles River Laboratories Internationaloption or derivative · Life-science tools | SEC FORM 4 Code A | $321K1,669 at $192.36 | filing |
| 15 May 2023filed 17 May 2023 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Code A | —664 at $0.00 | filing |
| 30 Nov 2022filed 2 Dec 2022 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —18,649 at $0.00 | filing |
| 11 May 2022filed 13 May 2022 | CRL Charles River Laboratories Internationaloption or derivative · Life-science tools | SEC FORM 4 Code A | $352K1,582 at $222.31 | filing |
| 11 May 2022filed 13 May 2022 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Code A | —575 at $0.00 | filing |
| 30 Nov 2021filed 2 Dec 2021 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —7,307 at $0.00 | filing |
| 6 Aug 2021filed 10 Aug 2021 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Code M | $417K2,539 at $164.24 | filing |
| 6 Aug 2021filed 10 Aug 2021 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Sold | $366K901 at $405.73 | filing |
| 6 Aug 2021filed 10 Aug 2021 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Sold | $1.1M2,620 at $406.67 | filing |
| 6 Aug 2021filed 10 Aug 2021 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Sold | $2,0365 at $407.29 | filing |
| 6 Aug 2021filed 10 Aug 2021 | CRL Charles River Laboratories Internationaloption or derivative · Life-science tools | SEC FORM 4 Code M | —2,539 at $0.00 | filing |
| 7 May 2021filed 10 May 2021 | CRL Charles River Laboratories Internationaloption or derivative · Life-science tools | SEC FORM 4 Code A | —1,151 at $0.00 | filing |
| 7 May 2021filed 10 May 2021 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Code A | —355 at $0.00 | filing |
News
Charles River Laboratories International, Inc. $CRL Stock: Yousif Capital Management LLC Boosts HoldingsCRL · dailypolitical.com · 24 Oct 2026Charles River Laboratories International (NYSE:CRL) versus VivoSim Labs (NASDAQ:VIVS) Head-To-Head ContrastCRL · dailypolitical.com · 22 Oct 2026
0 headlines in the last 90 days name Deborah Turner Kochevar; 2 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.